| Trial ID: | L4158 |
| Source ID: | NCT00686634
|
| Associated Drug: |
Sitagliptin
|
| Title: |
Sitagliptin in Combination With Metformin and Sulfonylurea
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00686634/results
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Sitagliptin
|
| Outcome Measures: |
Primary: Hemoglobin A1c (HbA1c) Change From Baseline, Baseline, 4 months | Secondary: Number of Subjects With Hemoglobin A1c 7.5% or Less at 4 Months, 4 months|Number of Subjects Maintaining Hemoglobin A1c 7.5% or Less by 1 Year, 1 year|Number of Adverse Events, 1 year
|
| Sponsor/Collaborators: |
Sponsor: Charles Drew University of Medicine and Science | Collaborators: National Center for Research Resources (NCRR)
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
108
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2008-01
|
| Completion Date: |
2010-03
|
| Results First Posted: |
2014-11-26
|
| Last Update Posted: |
2014-11-26
|
| Locations: |
Charles Drew University of Medicine and Science, Los Angeles, California, 90059, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00686634
|
